Genisphere and Lankenau Institute for Medical Research will develop a biomarker for ulcerative colitis and Crohn’s disease. Hopefully this will help doctors better pinpoint what patients might actually have and classify to what degree people have inflammatory bowel disease. A paper said that the biomarker could classify the severity and outcome of ulcerative colitis and able to tell who had colitis compared to those people that were healthy. Better tests are needed for inflammatory bowel disease as we know a colonoscopy can be a pain in the butt (thank you I will be here all week). The test could also be applied to cervical cancer and wound healing.